missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ OSBPL11 Monoclonal Antibody (OTI6H9)
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  Invitrogen™ MA525293

Product Code. 15984894

  • £474.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

OSBPL11 Monoclonal Antibody for Western Blot, ICC/IF

This gene encodes a member of the oxysterol-binding protein family, a group of intracellular lipid receptors. Like most members, the encoded protein contains an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

OSBPL11
Monoclonal
0.96 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q9BXB4
OSBPL11
Full length human recombinant protein of OSBPL11 produced in HEK293T cell.
100 μL
Primary
Human, Canine, Monkey
Antibody
IgG2b
Western Blot, Immunocytochemistry
OTI6H9
Unconjugated
OSBPL11
9430097N02Rik; AI132306; AU019795; FLJ13012; FLJ13164; ORP11; ORP-11; OSBP12; OSBPL11; OSBP-related protein 11; oxysterol binding protein like 11; oxysterol binding protein-like 11; oxysterol-binding protein-related protein 11; TCCCIA00292; testicular tissue protein Li 132
Mouse
Affinity Chromatography
RUO
100856388, 114885
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.